ZDRAVESKI ZORAN
SEC CIK 1741285 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TCRX | TScan Therapeutics, Inc. | See Remarks | 4,716 | $35.3K | $951.9K | 3 | 2021-09-23 | 2024-08-23 |
Most active insiders at TCRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lynx1 Capital Management LP | 10% | $145.6K | — |
ZDRAVESKI ZORAN made no open-market trades at TCRX in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-27 | 2024-08-23 | TCRX | TScan Therapeutics, Inc. | ZDRAVESKI ZORAN | See Remarks | S - Sale+OE | $5.78 | -164.7K | 4,716 | -97% | -$951.9K |
| DM | 2024-08-27 | 2024-08-23 | TCRX | TScan Therapeutics, Inc. | ZDRAVESKI ZORAN | See Remarks | M - OptEx | $3.38 | +157.2K | 67.1K | New | +$531.5K |
| 2021-09-27 | 2021-09-23 | TCRX | TScan Therapeutics, Inc. | ZDRAVESKI ZORAN | CLO | P - Purchase | $7.48 | +4,716 | 4,716 | New | +$35.3K |
Purchase Sale Sale after option exercise All abbreviations